Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma

NCT05053659 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Non Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma

Interventions

DRUG: Loncastuximab tesirine
DRUG: Venetoclax

Sponsor

Paolo Caimi, MD